Chemical Modulation of Gasdermin D Activity: Therapeutic Implications and Consequences
Overview
Authors
Affiliations
The gasdermin family of proteins are central effectors of the inflammatory, lytic cell death modality known as pyroptosis. Characterized in 2015, the most well-studied member gasdermin D can be proteolyzed, typically by caspases, to generate an active pore-forming N-terminal domain. At least well-studied three pharmacological inhibitors (necrosulfonamide, disulfiram, dimethyl fumarate) since 2018 have been shown to affect gasdermin D activity either through modulation of processing or interference with pore formation. A multitude of murine in vivo studies have since followed. Here, we discuss the current state of research surrounding these three inhibitors, caveats to their use, and a set of guiding principles that researchers should consider when pursuing further studies of gasdermin D inhibition.
Silva-Llanes I, Martin-Baquero R, Berrojo-Armisen A, Rodriguez-Cueto C, Fernandez-Ruiz J, de Lago E Antioxidants (Basel). 2024; 13(9).
PMID: 39334731 PMC: 11428793. DOI: 10.3390/antiox13091072.
Guo J, Zhang Q, Li Z, Qin M, Shi J, Wang Y Biomolecules. 2024; 14(6).
PMID: 38927129 PMC: 11201507. DOI: 10.3390/biom14060726.